Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have higher levels of certain androgens, which are good at predicting excess hair growth.

Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.

PCOS is a common hormonal disorder in women, treated with lifestyle changes, medication, and patient education.

The DHT immunoassay is unreliable due to high cross-reactivity with testosterone.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

HPE may help treat osteoarthritis by promoting cartilage regeneration.

PP405 shows promise as a new, effective treatment for hair loss with minimal side effects.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Testosterone increases 3α-androstanediol levels, which can be blocked by finasteride.

Finasteride helps induce ovulation in nonresponder PCOS women.

Removing both ovaries may better treat increased male hormone levels and related symptoms in postmenopausal women when hormone therapy doesn't work.

A new method accurately measures nine neuroactive steroids in small blood samples, helping to study brain diseases.

The document concludes that early and personalized treatment for PCOS in adolescents is crucial to manage symptoms and prevent long-term health issues.

The case highlights the complexity of diagnosing high testosterone in older women and the need for thorough testing.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Researchers created a new method to measure brain steroids, finding higher levels of certain steroids and changes due to a drug.

Non-classical 21 hydroxylase deficiency is an underdiagnosed cause of female hair loss and polycystic ovarian syndrome.

Lifestyle changes are more effective than medication for managing PCOS-related risks.

The document concludes that PCOS in teenagers is hard to diagnose, influenced by various factors, and should be managed with lifestyle changes and medication.

Prepubertal girls have higher sex steroid levels than boys, possibly leading to earlier puberty.

FOL-005, a new substance, was found to reduce hair growth without toxicity when injected into skin, suggesting it could be used to treat excessive hair growth.

More research is needed to understand the long-term benefits of insulin-sensitizing drugs for treating adolescents with PCOS.

Hair steroid profiling is a feasible, non-invasive alternative to serum analysis for assessing hormone levels and metabolism.

SPIOMET therapy may be a promising alternative to oral contraceptives for treating adolescent PCOS.

Acne and increased body hair in teenage girls are normal but severe cases may need hormone evaluation and treatment can prevent diabetes linked to PCO.

Anabolic steroid users may face higher risk of severe COVID-19.